US 8822699
Heterocyclic compound and use thereof
granted A61PA61P25/00A61P25/28
Quick answer
US patent 8822699 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P25/00, A61P25/28, A61P43/00